---
title: "PROMISE II 12-month data show durable outcomes with the LimFlow system in no-option CLTI patients"
date: "2023-11-03T21:31:12.000Z"
publishedDate: "3 novembre 2023"
summary: "One-year results from the PROMISE II US pivotal trial demonstrate the durability of outcomes of transcatheter arterialisation of the deep veins (TADV) using the LimFlow system (LimFlow) and that the procedure is safe and reproducible. Daniel Clair (Vanderbilt University Medical Center, Nashville, USA) recently presented the new data for the first time at VIVA 2023 [&#8230;] The post PROMISE II 12-month data show durable outcomes with the LimFlow system in no-option CLTI patients appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/promise-ii-12-month-data-show-durable-outcomes-with-the-limflow-system-in-no-option-clti-patients/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2023-11-03-promise-ii-12-month-data-show-durable-outcomes-with-the-limflow-system-in-no-option-clti-patients"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2023/11/Clair.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/promise-ii-12-month-data-show-durable-outcomes-with-the-limflow-system-in-no-option-clti-patients/"
---

![PROMISE II 12-month data show durable outcomes with the LimFlow system in no-option CLTI patients](https://vascularnews.com/wp-content/uploads/sites/7/2023/11/Clair.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/promise-ii-12-month-data-show-durable-outcomes-with-the-limflow-system-in-no-option-clti-patients/*

## L’essentiel

One-year results from the PROMISE II US pivotal trial demonstrate the durability of outcomes of transcatheter arterialisation of the deep veins (TADV) using the LimFlow system (LimFlow) and that the procedure is safe and reproducible. Daniel Clair (Vanderbilt University Medical Center, Nashville, USA) recently presented the new data for the first time at VIVA 2023 [&#8230;] The post PROMISE II 12-month data show durable outcomes with the LimFlow system in no-option CLTI patients appeared first on Vascular News .

## Lien source

https://vascularnews.com/promise-ii-12-month-data-show-durable-outcomes-with-the-limflow-system-in-no-option-clti-patients/
